We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

85 hedge funds and large institutions have $109M invested in BioSpecifics Technologies Corp. in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 4

160% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 15

39% more capital invested

Capital invested by funds: $78.6M → $109M (+$30.6M)

25% more funds holding

Funds holding: 68 → 85 (+17)

Holders
85
Holders Change
+17
Holders Change %
+25%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
39
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$2.57M
2
ECP
Elk Creek Partners
Colorado
+$2.44M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.31M
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$1.64M
5
RFC
Russell Frank Company
Washington
+$1.64M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$5.96M
2
RA
Royce & Associates
New York
-$1.45M
3
MCM
McKinley Capital Management
Alaska
-$1.19M
4
DCM
DAFNA Capital Management
California
-$1.01M
5
Franklin Resources
Franklin Resources
California
-$683K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$5.96M +$2.31M +60,586 +65%
Renaissance Technologies
2
Renaissance Technologies
New York
$5.6M +$1.38M +36,101 +33%
Franklin Resources
3
Franklin Resources
California
$5.55M -$683K -17,900 -11%
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.97M +$96.9K +2,540 +2%
TC
5
TFS Capital
Pennsylvania
$4.39M +$1.3M +34,030 +43%
AC
6
Armistice Capital
New York
$4.05M +$4.01M +105,000 New
BFA
7
BlackRock Fund Advisors
California
$4M +$490K +12,837 +14%
BIT
8
BlackRock Institutional Trust
California
$3.83M +$725K +18,996 +24%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$3.81M +$1.02M +26,661 +37%
Wells Fargo
10
Wells Fargo
California
$3.48M +$75.2K +1,971 +2%
NI
11
Numeric Investors
Massachusetts
$3.44M +$2.57M +67,485 +312%
NC
12
Northpointe Capital
Michigan
$3.34M +$1.47M +38,545 +81%
EI
13
EAM Investors
California
$3.03M +$867K +22,735 +41%
Morgan Stanley
14
Morgan Stanley
New York
$2.84M +$511K +13,388 +22%
ECP
15
Elk Creek Partners
Colorado
$2.47M +$2.44M +64,022 New
Northern Trust
16
Northern Trust
Illinois
$2.41M +$126K +3,303 +6%
BA
17
BlackRock Advisors
Delaware
$2.29M +$23.1K +605 +1%
ACA
18
Apis Capital Advisors
New York
$2.25M +$2.22M +58,200 New
MOACM
19
Mutual of America Capital Management
New York
$2.24M +$34.5K +904 +2%
Allianz Asset Management
20
Allianz Asset Management
Germany
$2.1M +$1.32M +34,577 +176%
GCP
21
GSA Capital Partners
United Kingdom
$2.08M +$320K +8,400 +18%
PAI
22
Palo Alto Investors
California
$1.95M +$576K +15,100 +43%
Charles Schwab
23
Charles Schwab
California
$1.91M – – –
RA
24
Royce & Associates
New York
$1.88M -$1.45M -38,000 -44%
RFC
25
Russell Frank Company
Washington
$1.8M +$1.64M +43,010 +1,026%
1
2 3 4

BSTC Hedge Fund Activity: Q4 2014 in Review

85 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2014, worth a combined $109M — up 39% from $78.6M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new BSTC positions and 4 closed out — a net gain of 17 holders — while 39 added to existing stakes and 15 trimmed.

The largest buyer was Numeric Investors, adding an estimated $2.57M. The largest seller was Deerfield Management, exiting entirely with an estimated $5.96M sold.

  • 85 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2014, up from 68 in Q3 2014.
  • Funds reported $109M of BioSpecifics Technologies Corp. stock for Q4 2014, up 39% quarter-over-quarter.
  • 21 funds opened new BioSpecifics Technologies Corp. positions in Q4 2014 and 4 closed out, a net change of +17 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2014 was Numeric Investors, an estimated $2.57M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2014 was Deerfield Management, an estimated $5.96M sold.

Based on aggregated 13F filings for Q4 2014.